aoui, Glaxo's chairman of Global Research =nd Development, at one of the company's 16 facilities he oversees =orldwide, this one in King of Prussia, Pa. Slaoui, who is 55 and has a Ph.D. in =olecular biology and immunology, was instrumental in developing the first malaria vaccine =nd is considered one of th